ClinicalTrials.gg
RecruitingNCT06764693PERISUpdated Feb 17, 2026

An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

An observational study in Psoriatic Arthritis, sponsored by AbbVie. Recruiting at 132 sites in 15 countries. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by AbbVie · Observational

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,200
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 34 studies in Arthritis, Psoriatic by AbbVie — 4 open to participants now, 6 under way, 3 of them phase 3. Arthritis, Psoriatic · AbbVie.

Planned enrollment
6th of 22
1,200 · median 474
Started
2025
with 1 other
Observational
22 of 34
2 open now
Registered
33rd of 34
by date

Among the 34 studies in Arthritis, Psoriatic by AbbVie, this one is the 6th largest by planned enrollment of the 22 observational ones that give a count, is one of 2 that started in 2025, is one of 22 observational ones, and was the 33rd registered.

Arthritis, Psoriatic

602 studies on the registry are indexed under Arthritis, Psoriatic; 129 are open to participants now.

Browse Arthritis, Psoriatic studies →

Open to participants now

4 of the 34 studies in Arthritis, Psoriatic by AbbVie are open now, in 12 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Who these studies take

Of the 89 Arthritis, Psoriatic studies recruiting now, 52 (58%) set no upper age limit and 28 (31%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Arthritis, Psoriatic by AbbVie, or all of them as a file.
02

Study summary

Psoriatic arthritis (PsA) is a type of arthritis (swelling and stiffness in the joints) that is frequently seen in trial participants who also have the skin condition psoriasis. It is caused by an overactive immune system where the body attacks healthy tissue by mistake. This study aims to describe the long term usage and effectiveness with risankizumab (RZB) relative to other advanced therapeutic options for the management of PsA in daily clinical practice.

Risankizumab is an approved drug for the treatment of psoriatic arthritis. The study will not be conducted in the United States, however it will be conducted in approximately 15 countries and include at least 900 and up to 1200 participants with a 2 to1 ratio of participant allocation between participants receiving risankizumab and participants receiving other advanced therapeutic agents.

The therapy is prescribed in the usual manner in accordance with the terms of the local marketing authorization and professional and reimbursement guidelines with regards to dose, population, and indication. All study visits will occur during routine clinical practice and participants will be followed for 24 months.

There is expected to be no additional burden for participants in this study.

03

Conditions studied

  • Psoriatic Arthritis

Browse trials for

Keywords

  • Risankizumab, Skyrizi
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants that currently are treated with Risankizumab or other advanced treatment options for the management of active psoriatic arthritis in clinical practice.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant with a clinical diagnosis of psoriatic arthritis (PsA) with symptom onset at least 6 months prior to the Screening visit and fulfillment of ClASsification for Psoriatic ARthritis (CASPAR) at Baseline visit to confirm that the participant has active disease.
  • Participant must have demonstrated an inadequate response to at least 1 Disease-modifying antirheumatic drug (DMARD) (with max 50% Biologic DMARD-Inadequate Response); alternatively, participant must have demonstrated an intolerance to or for csDMARDs as determined by the investigator.

Exclusion criteria

Exclusion Criteria:

- Participants demonstrated an inadequate response to three or more bDMARDs/targeted synthetic DMARDs (tsDMARDs).

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,200 participants (estimated)

Groups and cohorts

  • Biologic Disease-Modifying Antirheumatic Drugs (bDMARD)

    Participants will receive bDMARDs as prescribed by their physician according to local label.

  • Risankizumab

    Participants will receive risankizumab as prescribed by their physician according to local label.

06

What researchers measure

Primary outcomes

  1. Number of participants that show persistence in treatment until 24 months

    Persistence over 24 months, defined as a participant who starts PsA treatment and is still on the same therapy until 24 months.

    Time frame: 24 Months

07

Study locations

131 of 132 sites recruiting
  • Cer Instituto Médico /ID# 274445
    Quilmes, Buenos Aires 1878, Argentina
    Recruiting
  • Instituto Medico de Alta Complejidad San Isidro S.A. /ID# 274417
    San Isidro, Buenos Aires 1642, Argentina
    Recruiting
  • Instituto Médico Río Cuarto /ID# 274421
    Río Cuarto, Córdoba Province 5800, Argentina
    Recruiting
  • Landesklinikum Stockerau /ID# 275618
    Stockerau, Lower Austria 2000, Austria
    Recruiting
  • Rheuma-Zentrum Wien-Oberlaa GmbH /ID# 275617
    Vienna, State of Vienna 1100, Austria
    Recruiting
  • Medizinische Universitaet Graz /ID# 273765
    Graz, Styria 8010, Austria
    Recruiting
  • Krankenhaus Der Barmherzigen Brueder Graz /ID# 273764
    Graz, Styria 8020, Austria
    Recruiting
  • Universite Libre de Bruxelles - Hopital Erasme /ID# 272763
    Anderlecht, Brussels Capital 1070, Belgium
    Recruiting
  • Rhumaconsult Sprl /ID# 272797
    Charleroi, Hainaut 6000, Belgium
    Recruiting
  • Reumacentrum Genk - Medisch Centrum Genk /ID# 272796
    Genk, Limburg 3600, Belgium
    Recruiting
  • ReumaClinic /ID# 272782
    Genk, Limburg 3600, Belgium
    Recruiting
  • OLV Ziekenhuis Aalst /ID# 274456
    Aalst, Oost-Vlaanderen 9300, Belgium
    Recruiting
  • UZ Leuven /ID# 272781
    Leuven, Vlaams-Brabant 3000, Belgium
    Recruiting
  • CHU de Liege /ID# 272784
    Liège, 4000, Belgium
    Recruiting
  • Diagnostic Consultative Centre (Dcc) - Foкus 5 /ID# 275952
    Sofiya, Sofia 1463, Bulgaria
    Recruiting
  • Military Hospital - Pleven /ID# 276054
    Pleven, 5803, Bulgaria
    Recruiting
  • Medical Center Epiona /ID# 276037
    Plovdiv, 4001, Bulgaria
    Recruiting
  • University Multiprofile Hospital For Active Treatment Pulmed /ID# 276157
    Plovdiv, 4002, Bulgaria
    Recruiting
  • Dr. Tsvetanka Petranova ELIMED - 2 /ID# 276158
    Sofia, 1408, Bulgaria
    Recruiting
  • Medical Center Academy /ID# 276041
    Sofia, 1612, Bulgaria
    Recruiting
  • AIPSMPR -d-r Gerganov /ID# 275953
    Varna, 9002, Bulgaria
    Recruiting
  • MAPO revma /ID# 272409
    Ostrava, Ostrava-mesto 710 00, Czechia
    Recruiting
  • Fakultni Nemocnice Plzen /ID# 276061
    Pilsen, Praha 17 301 00, Czechia
    Recruiting
  • Centre Hospitalier Universitaire de Nice - Hopital Pasteur /ID# 274923
    Nice, Alpes-Maritimes 06001, France
    Recruiting
  • Infirmerie Protestante De Lyon /ID# 274922
    Caluire-et-Cuire, Auvergne-Rhône-Alpes 69300, France
    Recruiting
  • Centre Hospitalier Universitaire Gabriel-Montpied /ID# 275399
    Clermont-Ferrand, Auvergne-Rhône-Alpes 63000, France
    Recruiting
  • Chu Grenoble - Hôpital Sud /ID# 275200
    Échirolles, Auvergne-Rhône-Alpes 38130, France
    Recruiting
  • Centre Hospitalier Regional Universitaire de Besancon - Hopital Jean Minjoz /ID# 277881
    Besançon, Doubs 25000, France
    Recruiting
  • Centre Hospitalier D'Arras /ID# 275192
    Arras, Hauts-de-France 62022, France
    Recruiting
  • CHU de Lille - Hôpital Salengro /ID# 274980
    Lille, Hauts-de-France 59037, France
    Recruiting
  • Chu Montpellier /ID# 274925
    Montpellier, Herault 34295, France
    Recruiting
  • Chru De Rennes - Hôpital Sud /ID# 277115
    Rennes, Ille-et-Vilaine 35203, France
    Recruiting
  • Centre Hospitalier Régional Universitaire De Tours - Hôpital Trousseau /ID# 275397
    Chambray-lès-Tours, Indre-et-Loire 37170, France
    Recruiting
  • Clinique François Chénieux /ID# 276516
    Limoges, Limousin 87039, France
    Recruiting
  • CHU Limoges - Dupuytren 2 /ID# 274918
    Limoges, New Aquitaine 87000, France
    Recruiting
  • Pôle Santé du Pont de Chaume /ID# 275608
    Montauban, Occitanie 82000, France
    Recruiting
  • Centre Hospitalier Boulogne-Sur-Mer /ID# 277269
    Boulogne-sur-Mer, Pas-de-Calais 62321, France
    Recruiting
  • Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 275396
    Nantes, Pays de la Loire Region 44000, France
    Recruiting
  • Hôpital Privé De Provence /ID# 275797
    Aix-en-Provence, Provence-Alpes-Côte d'Azur Region 13080, France
    Recruiting
  • Centre Hospitalier De Cannes - Hôpital De Cannes /ID# 275193
    Cannes, Provence-Alpes-Côte d'Azur Region 06414, France
    Recruiting
  • Centre Hospitalier Universitaire de Rouen (CHU)- Hopital Charles Nicolle /ID# 275366
    Rouen, Seine-Maritime 76031, France
    Recruiting
  • Cabinet libéral du Dr PAUPIERE /ID# 275401
    Péronne, Somme 80200, France
    Recruiting
  • Henri Mondor Hospital /ID# 275360
    Créteil, Val-de-Marne 94000, France
    Recruiting
  • CH de Cahors /ID# 275092
    Cahors, 46005, France
    Recruiting
  • Centre Hospitalier Régional d'Orléans - Hôpital de la Source /ID# 275377
    Orléans, 45067, France
    Recruiting
  • AP-HP - Groupe Hospitalier 10e - Hopital Lariboisiere /ID# 275182
    Paris, 75010, France
    Recruiting
  • Groupe Hospitalier Paris Saint-Joseph /ID# 274981
    Paris, 75014, France
    Recruiting
  • Centre Hospitalier de Valenciennes /ID# 276354
    Valenciennes, 59300, France
    Recruiting
  • Centre Hospitalier Sud Francilien /ID# 275038
    Corbeil-Essonnes, Île-de-France Region 91106, France
    Recruiting
  • Hopital Pitie Salpetriere /ID# 275368
    Paris, Île-de-France Region 75013, France
    Recruiting
  • Dr. Med. Thomas Marycz /ID# 280489
    Amberg, Bavaria 92224, Germany
    Recruiting
  • Klinische Forschung Im Medizinischen Versorgungalltag Gbr /ID# 276208
    Planegg, Bavaria 82152, Germany
    Recruiting
  • Private Practice - Dr. Dirk Wernicke /ID# 279748
    Hohen Neuendorf, Brandenburg 16540, Germany
    Recruiting
  • Rheumatologisch Immunologisch /ID# 275832
    Templin, Brandenburg 17268, Germany
    Recruiting
  • Deutsches Endokrinologisches Versorgungszentrum DEVZ - MVZ GdR /ID# 276484
    Frankfurt am Main, Hesse 60329, Germany
    Recruiting
  • Rheumateam Lahn-Dill-Siegerland /ID# 276019
    Wetzlar, Hesse 35578, Germany
    Recruiting
  • Praxis. F. Bigdeli-Wilshusen /ID# 275522
    Hanover, Lower Saxony 30173, Germany
    Recruiting
  • Rheumatologie Kassel /ID# 276311
    Kassel, Lower Saxony 34125, Germany
    Recruiting
  • Rheumazentrum Ratingen /ID# 278190
    Ratingen, North Rhine-Westphalia 40882, Germany
    Recruiting
  • Praxis Dr. med. Florian Beyer /ID# 276233
    Kaiserslautern, Rhineland-Palatinate 67657, Germany
    Recruiting
  • Krankenhaus der Barmherzigen Brüder Trier /ID# 278759
    Trier, Rhineland-Palatinate 54292, Germany
    Recruiting
  • Knappschaftsklinikum Saar /ID# 279850
    Püttlingen, Saarland 66346, Germany
    Recruiting
  • Rheumapraxis Dr. Prothmann /ID# 275712
    Püttlingen, Saarland 66346, Germany
    Recruiting
  • Rheumapraxis Dr. Liebhaber /ID# 276235
    Halle, Saxony-Anhalt 06128, Germany
    Recruiting
  • Rheumatologische Facharztpraxis /ID# 276359
    Magdeburg, Saxony-Anhalt 39104, Germany
    Recruiting
  • Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 275711
    Lübeck, Schleswig-Holstein 23538, Germany
    Recruiting
  • Private Practice - Dr. Jochen Walter /ID# 280067
    Rendsburg, Schleswig-Holstein 24768, Germany
    Recruiting
  • Private Practice - Dr. Thomas Kupka /ID# 276236
    Altenburg, Thuringia 04600, Germany
    Completed

    Not enrolling at this site — choose another above.

  • Rheumapraxis Steglitz /ID# 279413
    Berlin, 12161, Germany
    Recruiting
  • Private Practice - Dr. Silke Zinke /ID# 279350
    Berlin, 13055, Germany
    Recruiting
  • MVZ Herzogin Elisabeth Hospital /ID# 275583
    Braunschweig, 38114, Germany
    Recruiting
  • Praxis Fiene /ID# 279363
    Greifswald, 17493, Germany
    Recruiting
  • Cellitinnen-Krankenhaus St. Josef /ID# 275710
    Wuppertal, 42105, Germany
    Recruiting
  • Olympion General Clinic /ID# 271685
    Pátrai, Achaia 25443, Greece
    Recruiting
  • Athens Naval Hospital /ID# 272313
    Athens, Attica 11521, Greece
    Recruiting
  • General Hospital of Athens Ippokratio /ID# 262528
    Athens, Attica 11527, Greece
    Recruiting
  • General Hospital of Athens Laiko /ID# 272325
    Athens, Attica 11527, Greece
    Recruiting
  • General Hospital of Athens Laiko /ID# 272410
    Athens, Attica 11527, Greece
    Recruiting
  • University General Hospital Attikon /ID# 272358
    Athens, Attica 12462, Greece
    Recruiting
  • Asklipieio General Hospital of Voula /ID# 272326
    Voula, Attica 16673, Greece
    Recruiting
  • University General Hospital of Heraklion /ID# 271743
    Heraklion, Crete 71500, Greece
    Recruiting
  • University General Hospital of Alexandroupolis /ID# 272411
    Alexandroupoli, Evros 68100, Greece
    Recruiting
  • The University Hospital of Larissa /ID# 272315
    Larissa, Larisa 41110, Greece
    Recruiting
  • KAT Atttica General Hospital /ID# 271741
    Athens, 14561, Greece
    Recruiting
  • General Hospital of Ioannina G. Hatzikosta /ID# 272327
    Ioannina, 45445, Greece
    Recruiting
  • Bioclinic Thessaloniki /ID# 272316
    Thessaloniki, 54622, Greece
    Recruiting
  • General Hospital of Thessaloniki Hippokrateio /ID# 272314
    Thessaloniki, 54642, Greece
    Recruiting
  • Euromedica General Clinic of Thessaloniki /ID# 272412
    Thessaloniki, 54645, Greece
    Recruiting
  • Euromedica General Clinic of Thessaloniki /ID# 275805
    Thessaloniki, 54645, Greece
    Recruiting
  • St James Hospital /ID# 260024
    Dublin, Dublin D08 NHY1, Ireland
    Recruiting
  • St Vincents University Hospital /ID# 261237
    Elm Park, Dublin D04 T6F4, Ireland
    Recruiting
  • University Hospital Kerry /ID# 266733
    Tralee, Kerry V92 NX94, Ireland
    Recruiting
  • Cork University Hospital /ID# 268263
    Cork, T12 E8YV, Ireland
    Recruiting
  • Beaumont Hospital /ID# 271961
    Dublin, D09 XR63, Ireland
    Recruiting
  • Tallaght University Hospital /ID# 277000
    Dublin, D24 NR0A, Ireland
    Recruiting
    • Site Coordinator · Contact01 414 3350
  • Meir Medical Center /ID# 273315
    Kfar Saba, Central District 4428164, Israel
    Recruiting
  • The Chaim Sheba Medical Center /ID# 273313
    Ramat Gan, Tel Aviv 5265601, Israel
    Recruiting
  • Tel Aviv Sourasky Medical Center /ID# 273311
    Tel Aviv, Tel Aviv 6423906, Israel
    Recruiting
  • The Lady Davis Carmel Medical Center /ID# 273312
    Haifa, 34362, Israel
    Recruiting
  • Hadassah Medical Center-Hebrew University /ID# 273314
    Jerusalem, 91120, Israel
    Recruiting

Showing the first 100 of 132 sites across 15 countries. Choose a country and city above to see the rest.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jan 2029, 48 months after the start.

Of 52 industry-sponsored observational studies under Arthritis, Psoriatic, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 63. This study's planned 48 months is close to that.

Counting every sponsor, half of 129 studies reached it within 47 months; a quarter within 28 and three quarters within 82.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2025
First posted
Jan 8, 2025
StartActual
Jan 31, 2025
Primary completionEst.
Jan 2029
CompletionEst.
Feb 2029
Last update
Feb 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06764693
Lead sponsor
AbbVie
Responsible party
Sponsor
First posted
Jan 8, 2025
Start date
Jan 31, 2025
Primary completion
Jan 2029 (estimated)
Completion
Feb 2029 (estimated)
Last update
Feb 17, 2026

Study contacts

Shari Chapman
Contact
shari.chapman@abbvie.com
844-663-3742
ABBVIE INC.
study director · AbbVie

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion